Dr. Huss has made significant contributions to the understanding and functional role of mesenchymal stromal cells in mammalian hematopoiesis and tissue regeneration.

He received his MD from the University of Erlangen-Nuremberg and was trained in immunology and transplantation medicine at the Department of Immunology in Zurich, Switzerland and the Fred Hutchinson Cancer Research Center in Seattle. Dr. Huss completed his residency in surgical and anatomical pathology at the University of Munich, where he eventually received his Ph.D. and was appointed Professor for Pathology.

In 2005, he joined Roche Diagnostics in Penzberg, Germany as the Head of Histopathology and Tissue Biomarker. There he was strongly involved in biomarker discovery to stratify cancer patients as part of a global Personalized Healthcare Strategy. Eventually, Dr. Huss was promoted VP in Pharma Research & Early Development and became the Global Head of the Roche Therapeutic Cell Initiative.

In October 2011, Dr. Huss joined the apceth management team as a co-founder, managing director and chief scientific officer.  He was also appointed to numerous advisory boards and is currently also an Adjunct Professor of Regenerative Medicine at the Wake Forest Institute for Regenerative Medicine in Winston-Salem.